11th International Congress of Human Genetics

Session Details

Genzyme Satellite Symposium on Lysosomal Storage Diseases “Recent Advancements and Emerging Strategies for the Treatment of Lysosomal Storage Disorders”

Sunday, 6 August 2006 14:30 -16:00

M4

The goal of this symposium is to review current and investigational therapeutic interventions for Lysosomal Storage Disorders. Objectives of the session are to compare and contrast relative strengths and weaknesses of the various approaches and discuss implications for future treatment strategies.

Chair Dr Jim McGill Royal Children’s Hospital, BrisbaneAustralia
Opening Comments
  • Dr Jim McGill, Royal Children’s Hospital, Brisbane, Australia
    • Recent Advancements in the Treatment of Pompe Disease
  • Dr Deborah Marsden, Director, Global Medical Programs-Genzyme Corp., United States
    • Emerging Therapeutic Strategies For the Treatment of Lysosomal Storage Diseases
  • Dr Tim Edmunds, Therapeutics Protein Research-Genzyme Corp., United States
    • Closing Comments/Questions
  • Dr Jim McGill, Royal Children’s Hospital, Brisbane, Australia
    • Published on Tuesday, 1 August 2006 by the Professional Conference Organiser